Diagnosis and treatment of myocardial damage in patients with covid-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/1214

Full metadata record

DC Field	Value	Language
dc.contributor.author	Asila K. Kuzieva, Kholmurod S. Akhmedov	-
dc.date.accessioned	2021-12-28T08:25:47Z	-
dc.date.available	2021-12-28T08:25:47Z	-
dc.date.issued	2021	-
dc.identifier.issn	2651-4451	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/1214	-
dc.description.abstract	The cardiovascular system's complications in the treatment of COVID-19 are one of the main problems facing doctors today. The greatest danger of the disease is for people with pathological changes in the vascular system. However, it was found that changes in the heart also occur in patients who have not previously experienced this problem.Some patients have hypercoagulation syndrome, accompanied by thrombosis and thromboembolism. According to the latest data, it is established that changes in the blood clotting system and heart muscle occur even when the disease occurs without clinical signs.	en_US
dc.language.iso	en	en_US
dc.subject	coronavirus, COVID-19, myocardial damage, arrhythmia, echocardiography, electrocardiography, Angiotensin-converting enzyme 2 (ACE II).	en_US
dc.title	Diagnosis and treatment of myocardial damage in patients with covid-19	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
4 Diagnosis and treatment of myocardial damage in patients with COVID-19 (SCOPUS).pdf		119.79 kB	Adobe PDF	View/Open

DSpace JSPUI